Strata Skin Sciences (SSKN)
(Delayed Data from NSDQ)
$0.44 USD
-0.02 (-3.28%)
Updated Mar 27, 2024 03:58 PM ET
After-Market: $0.45 +0.01 (1.15%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
SSKN 0.44 -0.02(-3.28%)
Will SSKN be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for SSKN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SSKN
New Strong Buy Stocks for February 14th
Strata Skin Sciences, Inc. (SSKN) Reports Q3 Loss, Tops Revenue Estimates
SSKN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Tabula Rasa Healthcare (TRHC) Reports Q3 Loss, Tops Revenue Estimates
Strata Skin Sciences, Inc. (SSKN) Reports Q2 Loss, Tops Revenue Estimates
Health Catalyst (HCAT) Reports Q2 Loss, Tops Revenue Estimates
Other News for SSKN
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
STRATA Skin Sciences, Inc. (SSKN) Q4 2023 Earnings Call Transcript
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
SSKN Stock Earnings: Strata Skin Sciences Misses EPS, Misses Revenue for Q4 2023
Earnings Scheduled For March 27, 2024